Today: 7 February 2026
Subscribe
Browse Category

NASDAQ:ATPC News 11 December 2025 - 17 December 2025

Agape ATP Corporation (ATPC) Stock News Today: After-Hours Spike on Dec. 17, 2025 as Investors Weigh Volatility Statement, Proxy Proposals, and Forecast Signals

Agape ATP Corporation (ATPC) Stock News Today: After-Hours Spike on Dec. 17, 2025 as Investors Weigh Volatility Statement, Proxy Proposals, and Forecast Signals

Agape ATP Corporation (NASDAQ: ATPC) is back on traders’ radars on December 17, 2025, after a sharp after-hours move to around $0.13 following a regular-session close near $0.09. Benzinga+2Public+2 That bounce is the latest twist in what can only be described as a violent December tape for ATPC: the stock suffered a single-day plunge of roughly 95% on Dec. 10, then staged a dramatic rebound the next session with extraordinary volume, before sliding again into mid-December. StockAnalysis So what’s behind today’s headline move—and what are investors focusing on next? The short answer: (1) the company’s recent statement addressing the volatility,
17 December 2025
··
Agape ATP (NASDAQ: ATPC) Stock Collapses to Penny Levels on Dec. 11, 2025: Price Crash, Dilution Fears and New Forecasts

Agape ATP (NASDAQ: ATPC) Stock Collapses to Penny Levels on Dec. 11, 2025: Price Crash, Dilution Fears and New Forecasts

Kuala Lumpur / New York – December 11, 2025 Agape ATP Corporation (NASDAQ: ATPC) has just done the stock‑market equivalent of base‑jumping without a parachute. On Wednesday, December 10, the health‑and‑energy micro‑cap plunged from about $1.32 to roughly $0.07, a single‑day drop of around 95%, on enormous volume. StockAnalysis+1By the next morning’s pre‑market session on December 11, the same stock was bouncing more than 100%–150% off those lows, changing hands around $0.13–$0.17 in early trading, even as its market capitalization sat near $3.4 million. StockAnalysis+2Benzinga+2 At the same time, multiple quantitative and technical services have flipped ATPC to “strong sell”
11 December 2025
··

Stock Market Today

AstraZeneca stock price: What could move AZN next week as earnings loom

AstraZeneca stock price: What could move AZN next week as earnings loom

7 February 2026
AstraZeneca shares rose Friday, closing at $193.03 in New York, up 3.1%, and 14,104p in London, up 0.9%. The company reports full-year and Q4 2025 results Tuesday, with investors focused on 2026 guidance. The FDA this week issued a complete response letter for a subcutaneous Saphnelo filing, while granting Priority Review to Datroway for breast cancer. AstraZeneca recently shifted its primary U.S. listing to the NYSE.
Go toTop